APTX Aptinyx Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: APTX

Price (delayed)

$0.151

Market cap

$10.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.07

Enterprise value

-$31.83M

Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has ...

Highlights
The company's quick ratio has surged by 65% QoQ and by 24% YoY
The EPS has contracted by 8% YoY but it has grown by 7% from the previous quarter
Aptinyx's net income has decreased by 8% YoY but it has increased by 8% from the previous quarter
The revenue has shrunk by 100% YoY
Aptinyx's gross profit has shrunk by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.aptinyx.com
Peers: OVID

Key stats

What are the main financial stats of APTX
Market
Shares outstanding
67.72M
Market cap
$10.23M
Enterprise value
-$31.83M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.21
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$70.32M
EBITDA
-$70.16M
Free cash flow
-$68.37M
Per share
EPS
-$1.07
Free cash flow per share
-$1.01
Book value per share
$0.72
Revenue per share
$0
TBVPS
$1.13
Balance sheet
Total assets
$76.21M
Total liabilities
$27.41M
Debt
$24.71M
Equity
$48.79M
Working capital
$71.26M
Liquidity
Debt to equity
0.51
Current ratio
27.45
Quick ratio
24.78
Net debt/EBITDA
0.6
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-74.2%
Return on equity
-102.3%
Return on invested capital
-280.9%
Return on capital employed
-95.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APTX stock price

How has the Aptinyx stock price performed over time
Intraday
-15.36%
1 week
10.62%
1 month
-73.6%
1 year
-94.51%
YTD
-47.07%
QTD
-47.07%

Financial performance

How have Aptinyx's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$70.31M
Net income
-$72.41M
Gross margin
N/A
Net margin
N/A
The revenue has shrunk by 100% YoY
Aptinyx's gross profit has shrunk by 100% YoY
The company's operating income rose by 9% QoQ but it fell by 5% YoY
Aptinyx's net income has decreased by 8% YoY but it has increased by 8% from the previous quarter

Growth

What is Aptinyx's growth rate over time

Valuation

What is Aptinyx stock price valuation
P/E
N/A
P/B
0.21
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 8% YoY but it has grown by 7% from the previous quarter
The price to book (P/B) is 88% lower than the 5-year quarterly average of 1.8 and 84% lower than the last 4 quarters average of 1.3
The equity has dropped by 56% year-on-year and by 21% since the previous quarter
The revenue has shrunk by 100% YoY

Efficiency

How efficient is Aptinyx business performance
Aptinyx's ROE has plunged by 106% YoY and by 13% from the previous quarter
APTX's ROIC has soared by 76% year-on-year and by 24% since the previous quarter
The company's return on assets has shrunk by 59% YoY and by 6% QoQ

Dividends

What is APTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APTX.

Financial health

How did Aptinyx financials performed over time
The total assets is 178% greater than the total liabilities
The company's current ratio has surged by 69% QoQ and by 30% YoY
The company's quick ratio has surged by 65% QoQ and by 24% YoY
The debt is 49% less than the equity
The debt has soared by 76% YoY
The equity has dropped by 56% year-on-year and by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.